| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 12.17T | 12.63T | 12.69T | 10.60T | 8.42T | 7.86T |
| Gross Profit | 1.42T | 1.69T | 2.07T | 1.71T | 1.35T | 1.05T |
| EBITDA | -140.92B | 360.76B | 1.36T | 800.72B | 1.13T | 406.91B |
| Net Income | -928.63B | -670.90B | 426.65B | 221.90B | 215.53B | -448.70B |
Balance Sheet | ||||||
| Total Assets | 19.70T | 19.02T | 19.86T | 17.60T | 16.37T | 16.45T |
| Cash, Cash Equivalents and Short-Term Investments | 2.21T | 2.20T | 2.13T | 2.01T | 1.79T | 2.03T |
| Total Debt | 9.23T | 8.14T | 7.81T | 7.04T | 7.13T | 7.60T |
| Total Liabilities | 14.37T | 13.58T | 13.38T | 11.98T | 11.34T | 12.11T |
| Stockholders Equity | 4.90T | 4.96T | 5.98T | 5.13T | 4.58T | 3.94T |
Cash Flow | ||||||
| Free Cash Flow | -856.79B | -1.16T | -666.88B | 87.55B | -276.70B | 140.48B |
| Operating Cash Flow | 850.48B | 753.69B | 960.90B | 1.22T | 847.19B | 1.32T |
| Investing Cash Flow | -696.74B | -971.23B | -812.66B | -447.04B | -146.84B | -369.12B |
| Financing Cash Flow | -191.51B | 263.25B | -131.55B | -670.61B | -1.09T | -639.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $307.09B | 12.27 | 10.34% | 2.57% | 7.28% | 12.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | $1.47T | 364.71 | 4.89% | ― | -2.93% | -47.22% | |
59 Neutral | $31.68B | 11.42 | 4.11% | 4.19% | 0.32% | -25.51% | |
57 Neutral | $69.85B | 23.64 | 4.34% | 0.69% | -1.29% | -49.96% | |
56 Neutral | $50.67B | ― | -20.26% | 5.64% | 3.75% | 33.37% | |
50 Neutral | $8.66B | -1.40 | -16.69% | ― | -2.50% | -751.08% |